

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | A$1.08 | A$455.37 A$387.06 Free shipping | |
| 180 pills | A$1.12 | A$238.02 A$202.32 | |
| 120 pills | A$1.14 | A$160.40 A$136.34 | |
| 90 pills | A$1.21 | A$129.35 A$109.95 | |
| 60 pills | A$1.25 | A$87.95 A$74.76 | |
| 30 pills | A$1.34 | A$46.55 A$39.57 | |
| 10 pills | A$1.54 | A$18.09 A$15.37 | |
| 360 pills | A$1.67 | A$708.94 A$602.60 Free shipping | |
| 180 pills | A$1.74 | A$367.39 A$312.28 Free shipping | |
| 120 pills | A$1.78 | A$250.96 A$213.31 | |
| 90 pills | A$1.87 | A$199.21 A$169.33 | |
| 60 pills | A$1.96 | A$137.11 A$116.54 | |
| 30 pills | A$2.09 | A$75.01 A$63.76 | |
| 10 pills | A$2.40 | A$28.44 A$24.17 |
Disclaimer: This information is designed for patient education and is not a substitute for medical advice. Consult a healthcare professional for personalised recommendations.
Prevacid is lansoprazole, a proton pump inhibitor (PPI) that reduces stomach acid production. This first sentence provides a complete definition of the medicine and its primary action.
The active ingredient is lansoprazole, and its drug class is the proton pump inhibitor (PPI). This class works by blocking a specific enzyme in the stomach lining that is responsible for acid production.
Its primary therapeutic purpose is to lessen acid-related irritation in the digestive tract. By lowering stomach acidity, symptoms such as heartburn may be relieved and healing of certain esophageal or gastric tissue can be promoted.
Prevacid is available in oral forms, including capsules and orally disintegrating tablets. These formulations are taken by mouth to deliver the active ingredient into the system.
In the Australian context, the use of lansoprazole may be guided by professional medical advice, with consideration given to patient-specific factors and local prescribing rules. The patient information leaflet supplied with the medicine should be consulted for formulation details and precise instructions.
Prevacid is used to manage conditions caused by excess stomach acid. Symptoms often relate to irritation from reflux or ulcers and may include a burning sensation in the chest or throat, difficulty swallowing, or persistent indigestion. The medication aims to relieve these symptoms and support healing of damaged tissue.
It is prescribed for a range of acid-related disorders, with treatment goals including symptom control, mucosal healing, and prevention of further irritation. The therapeutic aim is to restore a more normal balance of stomach acidity and protect the digestive tract lining.
Conditions commonly managed with lansoprazole include several acid-related disorders. The following list outlines typical indications and the contexts in which the medicine may be considered appropriate:
Off-label or extended use for persistent indigestion or dyspepsia may be considered in some cases, but such use should be guided by a clinician after appropriate evaluation. Seek professional advice if symptoms persist despite treatment or if new symptoms develop.
Prevacid reduces the production of gastric acid by blocking a key enzyme system in parietal cells of the stomach lining. This enzyme system, the proton pump, is responsible for secreting acid into the stomach.
By inhibiting the proton pump, the amount of acid available in the stomach decreases. The result is a higher (less acidic) gastric environment, which supports healing of irritated esophageal and gastric tissue and reduces symptoms related to acid exposure.
The effect is cumulative with continued use, and the medication works primarily in the stomach rather than affecting other organs. Drug action is relatively targeted, which helps limit widespread systemic effects while providing symptom relief for acid-related conditions.
In addition to acid suppression, the change in stomach pH can influence the absorption of some medicines that rely on a particular acidity level for optimal uptake. This interaction is considered when managing concurrent therapies. If new medicines are started, it is important to review potential effects on absorption with a clinician.
The dose and duration of treatment are determined by the prescriber and depend on the condition being treated, the response to therapy, and patient-specific factors. The information provided here is informational and should not replace professional instructions.
Prevacid is typically taken by mouth, usually once daily, and often before a meal. Timing can influence absorption and effectiveness, so following the prescribed schedule is important. Do not alter the schedule without consulting a clinician.
Swallow the capsule whole with a full glass of water. Do not chew or crush the capsule, unless directed by a healthcare professional. If the medication is a disintegrating tablet, follow the product-specific instructions for dispersion and ingestion.
If a dose is missed, take it as soon as remembered unless it is near the time for the next dose. Do not double the dose to catch up. If several doses are missed or if there is persistent vomiting, contact a healthcare professional for guidance.
Some formulations permit opening the capsule and sprinkling the granules on a small amount of soft food if swallowing is difficult. Do not chew the granules or mix with beverages unless explicitly allowed by the product instructions. Always check the official leaflet or ask a pharmacist for device- and formulation-specific guidance before altering administration.
Prevacid should not be used by individuals with a known allergy to lansoprazole or any other component of the formulation. A history of severe allergic reactions to PPIs or related medications is a reason to avoid this drug unless advised otherwise by a clinician.
Severe liver disease may necessitate caution or alternative therapy. In some cases, dose adjustments or closer monitoring are required when liver function is impaired.
Pregnancy and breastfeeding status should be discussed with a healthcare professional. The potential benefits and risks must be weighed, and alternatives explored if appropriate. The medication may be prescribed only when clearly needed and after risk assessment.
In pediatric patients, suitability depends on age and clinical circumstances. Consultation with a pediatrician is advised to determine safety and appropriate dosing for children and adolescents.
People with a history of porphyria or other rare metabolic conditions should inform their clinician, as certain medical histories may require special consideration or monitoring during PPI therapy.
Long-term or frequent use of proton pump inhibitors may be associated with certain risks. While rare, these risks can become more relevant with prolonged therapy, especially in older adults or those with additional risk factors. Monitoring and periodic reassessment are advised for sustained treatment.
Potential concerns during therapy include infections of the digestive tract, nutritional deficiencies, and interference with the absorption of certain nutrients. Vitamin B12 deficiency and low magnesium levels are among the concerns reported with extended use, particularly in those who are elderly or on long courses of therapy. Consultation with a clinician is advised if there are signs of deficiency.
Other precautions include the possibility of rebound acid hypersecretion after stopping the medication, and the need to differentiate persistent symptoms from other conditions such as stomach ulcers or, rarely, stomach cancer. If symptoms persist, worsen, or change in character, a medical review should be sought promptly.
Immunological or infectious risks associated with reduced stomach acidity may arise, especially if antibiotic therapies or other immune-modulating treatments are used concurrently. If new symptoms such as fever, severe abdominal pain, or persistent diarrhea develop, seek medical advice urgently.
In the context of surgery or planned procedures, inform healthcare providers that lansoprazole is being used. The short-term stopping or delaying of therapy may be considered under medical guidance in certain situations. Always discuss any planned changes with a clinician.
Common side effects include headache, abdominal pain, nausea, diarrhea, abdominal bloating, and flatulence. These effects are usually mild and tend to resolve with continued therapy or dose adjustment under medical supervision.
Less common side effects may include dizziness, skin rash, dry mouth, and changes in bowel habits. These effects may warrant medical discussion if they are persistent or troublesome.
Serious side effects requiring urgent medical attention include signs of an allergic reaction (swelling of face or throat, severe rash, trouble breathing), severe persistent vomiting, or yellowing of the skin or eyes with dark urine. Additional serious concerns may include symptoms of liver injury or severe electrolyte disturbances; medical evaluation is advised if any such symptoms occur.
Rare or long-term risks, such as bone fractures or severe deficiencies of nutrients, are generally associated with extended use and specific patient risk factors. Ongoing monitoring by a healthcare professional helps manage these risks appropriately.
Interactions may occur with medicines that require an acidic environment for absorption or with those that are metabolized by similar pathways. Caution is advised when combining lansoprazole with such agents, and patients should inform a clinician about all medicines being taken.
The following are examples of interactions commonly considered in clinical practice, though this list is not exhaustive. Always verify with a pharmacist or clinician before starting or stopping any medication.
Food and beverage generally do not produce dramatic interactions with lansoprazole, but lifestyle factors can influence symptoms. Always inform healthcare providers about recent or planned dietary changes or herbal supplements, as these may have indirect effects on symptom control or absorption of medicines.
Pregnancy involves a careful assessment of benefits and risks. Lansoprazole may be prescribed if the anticipated benefits to the mother outweigh potential risks to the fetus, but this decision requires clinician oversight. The absence of clear, universal safety data means individual clinical judgement is essential.
Breastfeeding is another context in which risk assessment is required. Lansoprazole passes into breast milk in small amounts; a healthcare professional will determine whether continued treatment is appropriate while breastfeeding or whether an alternative therapy should be used.
Anyone planning pregnancy, who is pregnant, or who is breastfeeding should discuss these factors with a clinician. If pregnancy occurs during therapy, inform the treating healthcare professional promptly to reassess the treatment plan.
Most individuals notice improvement in symptoms within days to a couple of weeks, though the speed of relief may vary. If symptoms persist or worsen after a reasonable period, consult a clinician for reassessment.
If a dose is missed, take it as soon as remembered unless it is close to the next dose. Do not double the next dose to catch up. If several doses are missed, seek medical guidance.
Prevacid is usually taken before meals for optimal effect, but the specific instruction depends on the prescribed regimen. If a dose was scheduled with food, follow that plan, and discuss any difficulties with a pharmacist or clinician.
The duration varies by condition and response. Some conditions require short courses, while others may need longer-term therapy under medical supervision. Regular follow-up is important to determine if ongoing therapy is needed.
A clinician may advise a gradual reduction rather than a sudden stop to minimise potential rebound symptoms. If symptoms recur after stopping, contact a healthcare professional for guidance.
Moderate consumption is not expected to cause severe interactions, but alcohol and caffeine can irritate the stomach and may worsen symptoms. Discuss overall dietary habits with a clinician if symptoms persist.
Travel itself does not typically alter the safety profile of lansoprazole, but irregular meals and changes in routine can affect symptoms. Maintain adherence to the prescribed schedule and bring the medication in the original packaging when possible.
Long-term use may be associated with specific risks, and periodic assessment by a clinician is advised. If there are new symptoms, weight loss, or persistent digestive changes, seek medical advice promptly.
Most people can drive while taking lansoprazole, but side effects such as dizziness or headache could temporarily affect alertness. If these occur, consider whether driving is appropriate and discuss with a clinician if needed.
Routine monitoring is not required for all patients, but certain scenarios warrant periodic tests. A clinician may order blood tests to monitor electrolyte levels, nutrient status, or liver function in extended courses or special populations.
Yes. Providing a complete list of medicines, including over-the-counter products and supplements, helps ensure safe co-use and minimizes interaction risks. The pharmacist can help adjust schedules or advise on separate dosing where appropriate.
Official patient information leaflets supplied with the medicine contain detailed product-specific information, including ingredients, storage, and exact administration instructions. These leaflets should be consulted for formulation-specific guidance and safety cautions.
Healthcare professionals, including pharmacists and doctors, are reliable sources for personalised advice. They can review medical history, current medications, and treatment goals to tailor lansoprazole therapy appropriately.
In the Australian context, regulatory information and national guidance may be available through official channels and pharmacy services. For questions about indications, dosing, or safety, contact a licensed clinician or pharmacist for clarification and appropriate testing if required.
If symptoms persist or new concerns arise, seek professional medical evaluation promptly. The use of this medicine should align with indications, monitoring plans, and local clinical guidelines.
14β21 days. Free from A$283.79 .
5β9 days. A$42.57
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
